MRK · Merck & Co., Inc.
$130.76
-0.31 (-0.24%)
At close · Jul 27
Market Cap
$323.72B
Shares
2.47B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Robert Davis | CEO | $20,797,845 |
| Dean Li | President of Merck Research Labs | $8,892,881 |
| Caroline Litchfield | CFO | $7,514,085 |
| Jennifer Zachary | General Counsel | $5,860,578 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $5,408,408 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert Davis | CEO | $23,186,064 |
| Betty Larson | Executive Vice President and Chief Human Resources Officer | $11,257,796 |
| Dean Li | President of Merck Research Labs | $10,086,332 |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | $9,098,531 |
| Caroline Litchfield | CFO | $7,507,778 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $6,163,163 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Robert Davis | CEO | $20,273,287 |
| Dean Li | President of Merck Research Labs | $9,779,414 |
| Caroline Litchfield | CFO | $8,300,385 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $6,240,360 |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | $6,197,890 |
| Betty Larson | Executive Vice President and Chief Human Resources Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Robert Davis | CEO | $18,650,093 |
| Chirfi Guindo | Chief Marketing Officer, Human Health | $13,937,264 |
| Kenneth Frazier | Chairman | $8,510,621 |
| Dean Li | President of Merck Research Labs | $7,766,063 |
| Caroline Litchfield | CFO | $5,922,657 |
| Jennifer Zachary | General Counsel | $5,896,628 |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | $5,618,828 |
| Betty Larson | Executive Vice President and Chief Human Resources Officer | — |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kenneth Frazier | Chairman | $15,196,920 |
| Robert Davis | CEO | $13,722,121 |
| Frank Clyburn | Chief Commercial Officer | $9,921,071 |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | $6,841,000 |
| Dean Li | President of Merck Research Labs | $5,480,919 |
| Jennifer Zachary | General Counsel | $5,185,745 |
| Caroline Litchfield | CFO | $4,596,630 |
| Chirfi Guindo | Chief Marketing Officer, Human Health | — |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kenneth Frazier | Chairman | $22,088,429 |
| Roger Perlmutter | President of Merck Research Labs | $7,824,068 |
| Robert Davis | CEO | $6,839,510 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $4,946,155 |
| Jennifer Zachary | General Counsel | $4,557,155 |
| Dean Li | President of Merck Research Labs | — |
| Frank Clyburn | Chief Commercial Officer | — |
| Caroline Litchfield | CFO | — |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | — |
| Chirfi Guindo | Chief Marketing Officer, Human Health | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kenneth Frazier | CEO | $27,648,475 |
| Roger Perlmutter | President of Merck Research Labs | $9,223,354 |
| Robert Davis | CEO | $7,727,188 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $5,418,593 |
| Jennifer Zachary | General Counsel | $5,045,720 |
| Dean Li | President of Merck Research Labs | — |
| Caroline Litchfield | CFO | — |
| Frank Clyburn | Chief Commercial Officer | — |
| Richard R. DeLuca | Executive Vice President and President, Merck Animal Health | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Kenneth Frazier | CEO | $20,934,504 |
| Roger Perlmutter | President of Merck Research Labs | $7,098,642 |
| Robert Davis | CFO | $6,620,840 |
| Jennifer Zachary | General Counsel | $5,193,619 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Kenneth Frazier | CEO | $17,643,087 |
| Roger Perlmutter | President of Merck Research Labs | $6,833,867 |
| Robert Davis | CFO | $6,310,899 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | — |
| Jennifer Zachary | General Counsel | — |
Key facts
CIK
310158
CUSIP
58933Y105
13F (30d)
1457 filings
1408 filers
Visit website
Investor relations